Akèy › Pirura Trombositopenik Idyopatik › Massachusetts › Boston
Etid klinik pou Pirura Trombositopenik Idyopatik nan Boston, MA
6 etid pou Pirura Trombositopenik Idyopatik ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Massachusetts General Hospital, Boston
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
Ap rekriteFaz 2
- Beth Israel Deaconess Medical Center, Boston
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Ap rekriteFaz 2
- Beth Israel Deaconess Medical Center, Boston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Ap rekriteFaz 3
- Massachusetts General Hospital, Boston
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Ap rekriteFaz 3
- Massachusetts General Hospital Cancer Center, Boston
- Beth Israel Deaconess Medical Center, Boston
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
Ap rekriteEtid obsèvasyon
- Massachusetts General Hospital, Boston
Etid Pirura Trombositopenik Idyopatik nan lòt vil
- Los Angeles, CA7 etid
- Greenville, NC6 etid
- Washington, DC6 etid
- The Bronx, NY5 etid
- Durham, NC4 etid
- Rochester, MN4 etid
- Seattle, WA4 etid
- Houston, TX4 etid
- Portland, OR4 etid
- New Orleans, LA3 etid
- Cedar Rapids, IA3 etid
- New Haven, CT3 etid
Lòt etid nan Boston
- Kansè nan tete112 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)85 etid
- Kansè Metastatik63 etid
- Kansè kolorektal63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.